ICON PLC
NASDAQ:ICLR

Watchlist Manager
ICON PLC Logo
ICON PLC
NASDAQ:ICLR
Watchlist
Price: 186.465 USD 0.86% Market Closed
Market Cap: 14.2B USD

Operating Margin

14%
Current
Improving
by 0.8%
vs 3-y average of 13.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14%
=
Operating Income
$1.1B
/
Revenue
$8.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14%
=
Operating Income
$1.1B
/
Revenue
$8.1B

Peer Comparison

Country Company Market Cap Operating
Margin
IE
ICON PLC
NASDAQ:ICLR
14.2B USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
241B USD
Loading...
US
Danaher Corp
NYSE:DHR
170.9B USD
Loading...
CH
Lonza Group AG
SIX:LONN
38.3B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.6B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.5B USD
Loading...
US
Waters Corp
NYSE:WAT
23.7B USD
Loading...

Market Distribution

Higher than 75% of companies in Ireland
Percentile
75th
Based on 294 companies
75th percentile
14%
Low
-5 292.3% — 0.1%
Typical Range
0.1% — 13.7%
High
13.7% — 178.8%
Distribution Statistics
Ireland
Min -5 292.3%
30th Percentile 0.1%
Median 9.5%
70th Percentile 13.7%
Max 178.8%

ICON PLC
Glance View

In the rapidly evolving landscape of global healthcare, ICON PLC stands out as a formidable player, seamlessly bridging the gap between innovative drug development and practical clinical application. Founded in Dublin, Ireland, ICON has grown into a multinational enterprise, deeply embedded in the research and development phases of various medical and biopharmaceutical companies. The company's core strength lies in its ability to offer comprehensive clinical trial services, encompassing every stage of drug development, from initial study design through to final data management and regulatory submissions. ICON's systematic approach not only shortens the timeline for bringing novel therapeutics to market but also ensures that these breakthroughs are both effective and safe, thereby garnering trust from clients ranging from burgeoning biotech startups to pharmaceutical giants. As a contract research organization (CRO), ICON operates within a business model designed to capitalize on the booming demand for outsourced R&D support. This model involves entering into strategic partnerships with clients to conduct all necessary research activities in exchange for fees, which can be structured through agreements for specific projects or longer-term collaborations. The company leverages its robust network, sophisticated technological platforms, and expert workforce to offer tailored solutions that optimize efficiency and accuracy. By doing so, ICON not only enhances its clients’ product pipelines but also secures a steady stream of revenue, further consolidated through repeat business and the expansion of its service repertoire to include emerging areas like digital health and real-world evidence. This disciplined and innovative approach propels ICON's growth, ensuring its financial health and reaffirming its integral role in driving medical advancement worldwide.

ICLR Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
14%
=
Operating Income
$1.1B
/
Revenue
$8.1B
What is ICON PLC's current Operating Margin?

The current Operating Margin for ICON PLC is 14%, which is above its 3-year median of 13.2%.

How has Operating Margin changed over time?

Over the last 3 years, ICON PLC’s Operating Margin has increased from 10.9% to 14%. During this period, it reached a low of 10.9% on Sep 30, 2022 and a high of 14.7% on Dec 31, 2024.

Back to Top